NICOLAU SYNDROME: CUTANEOUS NECROSIS FOLLOWING DICLOFENAC INTRAMUSCULAR INJECTION.

Q4 Medicine
Georgian medical news Pub Date : 2025-04-01
N Bhuyyar, B Khombare, A Panicker, Sh Teli, M Shalavadi, K Choudhari
{"title":"NICOLAU SYNDROME: CUTANEOUS NECROSIS FOLLOWING DICLOFENAC INTRAMUSCULAR INJECTION.","authors":"N Bhuyyar, B Khombare, A Panicker, Sh Teli, M Shalavadi, K Choudhari","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nicolau syndrome, although it is quite rare, often occurs following Intramuscular injections of different medications, especially diclofenac and pencillin's. Accordingly, its symptoms usually begin with severe pain during injection, leading to ulceration and necrosis of the local tissue over time. Immediate diagnosis and treatment in the case of the syndrome are of great Importance. Diclofenac is class of NSAID's act as anti-inflammatory drug through inhibiting the Cycloxygenase-I and Cycloxygenase-II (COX-I AND COX-II) enzymes.</p><p><strong>Case report: </strong>In our case report we report the case of a 23-year-old female who developed the Nicolau Syndrome after an intramuscular injection in her left gluteal region of single dose diclofenac sodium to treat a headache, body ache, and chills. A physical examination revealed skin necrosis with the size of approximately 5×5cm. The patient was managed by administering intravenous antibiotics and analgesics, followed by surgical debridement, leading to satisfactory wound healing.</p><p><strong>Conclusion: </strong>This case highlights the importance of recognizing early warning signs of NS and adopting safe injection practices to prevent this serious adverse effect. Clinicians should be aware of the potential risks associated with intramuscular injections and take steps to minimize them.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 361","pages":"127-128"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Georgian medical news","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Nicolau syndrome, although it is quite rare, often occurs following Intramuscular injections of different medications, especially diclofenac and pencillin's. Accordingly, its symptoms usually begin with severe pain during injection, leading to ulceration and necrosis of the local tissue over time. Immediate diagnosis and treatment in the case of the syndrome are of great Importance. Diclofenac is class of NSAID's act as anti-inflammatory drug through inhibiting the Cycloxygenase-I and Cycloxygenase-II (COX-I AND COX-II) enzymes.

Case report: In our case report we report the case of a 23-year-old female who developed the Nicolau Syndrome after an intramuscular injection in her left gluteal region of single dose diclofenac sodium to treat a headache, body ache, and chills. A physical examination revealed skin necrosis with the size of approximately 5×5cm. The patient was managed by administering intravenous antibiotics and analgesics, followed by surgical debridement, leading to satisfactory wound healing.

Conclusion: This case highlights the importance of recognizing early warning signs of NS and adopting safe injection practices to prevent this serious adverse effect. Clinicians should be aware of the potential risks associated with intramuscular injections and take steps to minimize them.

Nicolau综合征:肌内注射双氯芬酸后皮肤坏死。
背景:Nicolau综合征,虽然非常罕见,但经常发生在肌肉注射不同药物后,特别是双氯芬酸和青霉素。因此,其症状通常始于注射时的剧烈疼痛,随着时间的推移导致局部组织溃疡和坏死。在这种情况下,及时诊断和治疗是非常重要的。双氯芬酸是一类通过抑制环氧化酶i和环氧化酶ii (COX-I和COX-II)酶而发挥抗炎作用的非甾体抗炎药。病例报告:在我们的病例报告中,我们报告了一例23岁的女性,她在左臀肌区肌内注射单剂量双氯芬酸钠治疗头痛、身体疼痛和寒颤后出现了尼科劳综合征。体格检查发现皮肤坏死,大小约为5×5cm。患者给予静脉注射抗生素和止痛药,随后进行手术清创,伤口愈合满意。结论:本病例强调了认识NS早期预警信号和采取安全注射措施以预防严重不良反应的重要性。临床医生应该意识到与肌内注射相关的潜在风险,并采取措施尽量减少风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Georgian medical news
Georgian medical news Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
207
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信